---
figid: PMC3497899__12079_2012_179_Fig3_HTML
figlink: /pmc/articles/PMC3497899/figure/Fig3/
number: F3
caption: A summary of how microenvironmental factors typically affect signaling pathways
  regulating alternative splicing and translation. Blue arrows indicate activating
  effects, although not necessarily an active protein, and red bars indicate inhibiting
  effects. Extracellular activation of PI3K causes an activation of AKT resulting
  in the phosphorylation of SR proteins and mTOR, directly altering splicing patterns
  and the dynamics of translation, respectively. Inhibition of mTOR enhances cap-independent
  translation through derepression of 4EBP causing inactivation of eIF4E. The RAS/MEK
  pathway is also involved in promoting cap-independent translation through other
  eIF proteins. Components of both of these pathways (AKT and ERK), also phosphorylate
  SR proteins, altering their RNA binding specificities and thus patterns of splicing
pmcid: PMC3497899
papertitle: Post-transcriptional regulation in cancer progression.
reftext: Michael Jewer, et al. J Cell Commun Signal. 2012 Dec;6(4):233-248.
pmc_ranked_result_index: '42707'
pathway_score: 0.9798053
filename: 12079_2012_179_Fig3_HTML.jpg
figtitle: Summary of how microenvironmental factors typically affect signaling pathways
  regulating alternative splicing and translation
year: '2012'
organisms: Homo sapiens
ndex: 9a8756a9-debc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3497899__12079_2012_179_Fig3_HTML.html
  '@type': Dataset
  description: A summary of how microenvironmental factors typically affect signaling
    pathways regulating alternative splicing and translation. Blue arrows indicate
    activating effects, although not necessarily an active protein, and red bars indicate
    inhibiting effects. Extracellular activation of PI3K causes an activation of AKT
    resulting in the phosphorylation of SR proteins and mTOR, directly altering splicing
    patterns and the dynamics of translation, respectively. Inhibition of mTOR enhances
    cap-independent translation through derepression of 4EBP causing inactivation
    of eIF4E. The RAS/MEK pathway is also involved in promoting cap-independent translation
    through other eIF proteins. Components of both of these pathways (AKT and ERK),
    also phosphorylate SR proteins, altering their RNA binding specificities and thus
    patterns of splicing
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - BRAF
  - MTOR
  - RAF1
  - MAP2K1
  - MAP2K2
  - PIK3R5
  - AKT1
  - MAPK1
  - MAPK3
  - ARAF
  - PIK3R3
  - KHDRBS1
  - PIK3CB
  - PIK3CG
  - AKT3
  - PIK3CA
  - KRAS
  - AKT2
  - PIK3CD
  - PIK3R4
  - HRAS
  - NRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Sam68
  symbol: Sam68
  source: hgnc_alias_symbol
  hgnc_symbol: KHDRBS1
  entrez: '10657'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3497899__F3
redirect_from: /figures/PMC3497899__F3
figtype: Figure
---
